![]() |
|
![]() |
|
| Systematic (IUPAC) name | |
|---|---|
| N-(4-bromophenyl)adamantan-2-amine | |
| Identifiers | |
| CAS number | 87913-26-6 |
| ATC code | none |
| PubChem | 4660557 |
| Chemical data | |
| Formula | C 16H20BrN |
| Mol. mass | 306.246 g/mol |
| SMILES | eMolecules & PubChem |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. | ? |
| Legal status | Legal |
| Routes | ? |
Bromantane is a stimulant drug developed in Russia during the late 1980s,[1][2] which acts mainly by inhibiting the reuptake of both dopamine and serotonin in the brain,[3][4][5][6] although it also has anticholinergic effects at very high doses.[7][8] It was used as a doping agent to enhance athletic performance, and several athletes tested positive for the drug at the 1996 Atlanta Olympic Games,[9] following which it was added to the banned list. Research on this class of drugs has been fairly extensive and a large family of derivatives are known, although bromantane remains the best studied,[10] and human trials continue for applications such as increasing endurance under extreme conditions.[11]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|